DrugDashboards

Chlorpromazine Hydrochloride

Chlorpromazine Hydrochloride · CHLORPROMAZINE HYDROCHLORIDE 25 mg/1 · Tablet, Film Coated · Oral · Glenmark Pharmaceuticals Inc., USA

NDC 68462-0862-10 · 1000 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →

The short version

9 companies supply this market — a reasonable cushion if one runs into trouble. One of its named manufacturing plants, Glenmark Pharmaceuticals Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for chlorpromazine hydrochloride (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA212144
TE code
AB
Approval date
Mar 23, 2021
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · OngoingMar 11, 2025
    Glenmark Pharmaceuticals Inc., USA — CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit.
  • Class II · OngoingDec 11, 2024
    Glenmark Pharmaceuticals Inc., USA — CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.
  • Class II · OngoingDec 11, 2024
    Glenmark Pharmaceuticals Inc., USA — CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.

Manufacturers of Chlorpromazine Hydrochloride (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Remedyrepack Inc.CHLORPROMAZINE HYDROCHLORIDE 25 mg/1Sep 3, 2026Sep 3, 2026
American Health PackagingCHLORPROMAZINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingCHLORPROMAZINE HYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingCHLORPROMAZINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingCHLORPROMAZINE HYDROCHLORIDE 200 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingCHLORPROMAZINE HYDROCHLORIDE 100 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals NY LLCCHLORPROMAZINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals NY LLCCHLORPROMAZINE HYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals NY LLCCHLORPROMAZINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals NY LLCCHLORPROMAZINE HYDROCHLORIDE 200 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals NY LLCCHLORPROMAZINE HYDROCHLORIDE 100 mg/1Jul 15, 2026Sep 2, 2026
AvPAKCHLORPROMAZINE HYDROCHLORIDE 200 mg/1Jul 15, 2026Sep 2, 2026
AvPAKCHLORPROMAZINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
AvPAKCHLORPROMAZINE HYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 2, 2026
AvPAKCHLORPROMAZINE HYDROCHLORIDE 100 mg/1Jul 15, 2026Sep 2, 2026
AvPAKCHLORPROMAZINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., USACHLORPROMAZINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., USACHLORPROMAZINE HYDROCHLORIDE 100 mg/1Jul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., USACHLORPROMAZINE HYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., USACHLORPROMAZINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., USACHLORPROMAZINE HYDROCHLORIDE 200 mg/1Jul 15, 2026Sep 2, 2026
Northstar Rx LLCCHLORPROMAZINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Northstar Rx LLCCHLORPROMAZINE HYDROCHLORIDE 100 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.CHLORPROMAZINE HYDROCHLORIDE 200 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.CHLORPROMAZINE HYDROCHLORIDE 100 mg/1Jul 15, 2026Sep 2, 2026
Upsher-Smith Laboratories, LLCCHLORPROMAZINE HYDROCHLORIDE 200 mg/1Jul 15, 2026Sep 2, 2026
Upsher-Smith Laboratories, LLCCHLORPROMAZINE HYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 2, 2026
Upsher-Smith Laboratories, LLCCHLORPROMAZINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Upsher-Smith Laboratories, LLCCHLORPROMAZINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Upsher-Smith Laboratories, LLCCHLORPROMAZINE HYDROCHLORIDE 100 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedCHLORPROMAZINE HYDROCHLORIDE 100 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedCHLORPROMAZINE HYDROCHLORIDE 200 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedCHLORPROMAZINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedCHLORPROMAZINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedCHLORPROMAZINE HYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals (USA) Inc.CHLORPROMAZINE HYDROCHLORIDE 200 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals (USA) Inc.CHLORPROMAZINE HYDROCHLORIDE 100 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals (USA) Inc.CHLORPROMAZINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals (USA) Inc.CHLORPROMAZINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals (USA) Inc.CHLORPROMAZINE HYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Chlorpromazine Hydrochloride — NDC 68462-0862-10," retrieved September 3, 2026, https://drugdashboards.com/drug/68462086210.

Free to cite with attribution — see how the data is put together.